Greytown Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Greytown Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$817K	Sell	8,812 -384	-4%	-$34.4K	0.48%	30
2024 Q1	$873K	Sell	9,196 -2,886	-24%	-$268K	0.49%	27
2023 Q4	$1.08M	Sell	12,082 -1,434	-11%	-$106K	0.58%	30
2023 Q3	$987K	Buy	13,516 +82	+0.6%	+$6.55K	0.55%	30
2023 Q2	$1.12M	Sell	13,434 -98	-0.7%	-$8.2K	0.61%	27
2023 Q1	$1.03M	Hold	13,532	–	–	0.53%	28
2022 Q4	$1.12M	Buy	13,532 +962	+8%	+$77.9K	0.61%	25
2022 Q3	$997K	Buy	12,570 +1,205	+11%	+$102K	0.6%	26
2022 Q2	$844K	Buy	11,365 +3,224	+40%	+$242K	0.48%	37
2022 Q1	$732K	Buy	+8,141	New	+$752K	0.35%	53

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Greytown Advisors's XBI Position: Q2 2024 in Review

Greytown Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4.2% in Q2 2024, selling an estimated $34.4K and leaving 8,812 shares worth $817K. The position accounts for 0.48% of the portfolio, ranked #30.

Greytown Advisors first reported a position in XBI in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.12M in Q4 2022. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Greytown Advisors held 8,812 shares of State Street SPDR S&P Biotech ETF worth $817K as of Q2 2024.
Greytown Advisors sold 384 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $34.4K.
State Street SPDR S&P Biotech ETF made up 0.48% of Greytown Advisors's portfolio in Q2 2024, its #30 holding.
Greytown Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 10 quarters since.
Greytown Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q4 2022.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Greytown Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.